(PFLT) PennantPark Floating Rate - Overview
Stock: Senior Loans, Mezzanine Debt, Equity Warrants, Preferred Stock
| Risk 5d forecast | |
|---|---|
| Volatility | 25.8% |
| Relative Tail Risk | 3.38% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.86 |
| Alpha | -28.78 |
| Character TTM | |
|---|---|
| Beta | 0.598 |
| Beta Downside | 0.834 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.85% |
| CAGR/Max DD | 0.21 |
EPS (Earnings per Share)
Revenue
Description: PFLT PennantPark Floating Rate March 02, 2026
PennantPark Floating Rate Capital Ltd. (NYSE: PFLT) is a Business Development Company that focuses on secondary direct investments in floating-rate loans, senior secured debt, mezzanine debt and related equity instruments. It targets private or thinly-traded middle-market companies-primarily U.S. based-with investment sizes typically ranging from $2 million to $20 million for direct deals and $10 million to $50 million for senior secured and mezzanine loans. Roughly 30 % of the portfolio may include non-qualifying assets such as larger public equities or distressed debt, while at least 80 % of net assets (plus any borrowings) are allocated to floating-rate loans and cash equivalents, with senior secured loans expected to comprise about 65 % of holdings.
As of the latest quarter (Q4 2023), PFLT reported a net asset value (NAV) of $13.45 per share and total assets under management of approximately $520 million. The fund’s distribution yield stood at 8.5 %, reflecting its emphasis on higher-yielding floating-rate credit. In the current macro environment, the Federal Reserve’s higher policy rates have boosted floating-rate loan spreads, making the sector attractive for income-focused investors, while credit-quality metrics remain stable with average loan ratings in the BB-CCC range.
For a deeper dive into PFLT’s performance metrics and valuation outlook, consider exploring additional analysis on ValueRay.
Headlines to watch out for
- Floating interest rates directly impact loan portfolio income
- Middle market credit health dictates investment performance
- Regulatory changes for BDCs affect operational flexibility
- Non-qualifying asset performance diversifies revenue streams
- Loan default rates influence portfolio valuation and write-downs
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 34.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 40.02 > 1.0 |
| NWC/Revenue: 36.37% < 20% (prev 63.49%; Δ -27.12% < -1%) |
| CFO/TA 0.04 > 3% & CFO 99.7m > Net Income 34.5m |
| Net Debt (1.54b) to EBITDA (35.6m): 43.16 < 3 |
| Current Ratio: 2.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (99.2m) vs 12m ago 21.50% < -2% |
| Gross Margin: 32.55% > 18% (prev 0.63%; Δ 3192 % > 0.5%) |
| Asset Turnover: 5.74% > 50% (prev 8.39%; Δ -2.65% > 0%) |
| Interest Coverage Ratio: 0.36 > 6 (EBITDA TTM 35.6m / Interest Expense TTM 98.0m) |
Altman Z'' -0.11
| A: 0.02 (Total Current Assets 95.3m - Total Current Liabilities 42.4m) / Total Assets 2.72b |
| B: -0.07 (Retained Earnings -179.2m / Total Assets 2.72b) |
| C: 0.01 (EBIT TTM 35.6m / Avg Total Assets 2.53b) |
| D: -0.11 (Book Value of Equity -179.1m / Total Liabilities 1.68b) |
| Altman-Z'' Score: -0.11 = B |
Beneish M
| DSRI: 0.41 (Receivables 13.0m/43.0m, Revenue 145.3m/196.7m) |
| GMI: 1.94 (GM 32.55% / 63.07%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 0.74 (Revenue 145.3m / 196.7m) |
| TATA: -0.02 (NI 34.5m - CFO 99.7m) / TA 2.72b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of PFLT shares?
Over the past week, the price has changed by -2.29%, over one month by -12.86%, over three months by -11.89% and over the past year by -17.31%.
Is PFLT a buy, sell or hold?
- StrongBuy: 2
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PFLT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.4 | 28.3% |
| Analysts Target Price | 10.4 | 28.3% |
PFLT Fundamental Data Overview March 09, 2026
P/E Forward = 8.5763
P/S = 3.0459
P/B = 0.7953
P/EG = 0.266
Revenue TTM = 145.3m USD
EBIT TTM = 35.6m USD
EBITDA TTM = 35.6m USD
Long Term Debt = 1.45b USD (estimated: total debt 1.63b - short term 184.8m)
Short Term Debt = 184.8m USD (from shortTermDebt, last quarter)
Debt = 1.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.54b USD (from netDebt column, last quarter)
Enterprise Value = 2.34b USD (805.6m + Debt 1.63b - CCE 95.3m)
Interest Coverage Ratio = 0.36 (Ebit TTM 35.6m / Interest Expense TTM 98.0m)
EV/FCF = 23.49x (Enterprise Value 2.34b / FCF TTM 99.7m)
FCF Yield = 4.26% (FCF TTM 99.7m / Enterprise Value 2.34b)
FCF Margin = 68.62% (FCF TTM 99.7m / Revenue TTM 145.3m)
Net Margin = 23.71% (Net Income TTM 34.5m / Revenue TTM 145.3m)
Gross Margin = 32.55% ((Revenue TTM 145.3m - Cost of Revenue TTM 98.0m) / Revenue TTM)
Gross Margin QoQ = -5.40% (prev 44.64%)
Tobins Q-Ratio = 0.86 (Enterprise Value 2.34b / Total Assets 2.72b)
Interest Expense / Debt = 1.66% (Interest Expense 27.2m / Debt 1.63b)
Taxrate = 1.68% (1.13m / 67.5m)
NOPAT = 35.0m (EBIT 35.6m * (1 - 1.68%))
Current Ratio = 2.25 (Total Current Assets 95.3m / Total Current Liabilities 42.4m)
Debt / Equity = 1.57 (Debt 1.63b / totalStockholderEquity, last quarter 1.04b)
Debt / EBITDA = 43.16 (Net Debt 1.54b / EBITDA 35.6m)
Debt / FCF = 15.41 (Net Debt 1.54b / FCF TTM 99.7m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.36% (Net Income 34.5m / Total Assets 2.72b)
RoE = 3.23% (Net Income TTM 34.5m / Total Stockholder Equity 1.07b)
RoCE = 1.42% (EBIT 35.6m / Capital Employed (Equity 1.07b + L.T.Debt 1.45b))
RoIC = 1.34% (NOPAT 35.0m / Invested Capital 2.61b)
WACC = 3.78% (E(805.6m)/V(2.44b) * Re(8.12%) + D(1.63b)/V(2.44b) * Rd(1.66%) * (1-Tc(0.02)))
Discount Rate = 8.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 29.97%
[DCF] Terminal Value 80.82% ; FCFF base≈99.7m ; Y1≈65.5m ; Y5≈29.9m
[DCF] Fair Price = N/A (negative equity: EV 951.7m - Net Debt 1.54b = -585.1m; debt exceeds intrinsic value)
EPS Correlation: -32.00 | EPS CAGR: -1.89% | SUE: -0.76 | # QB: 0
Revenue Correlation: 56.69 | Revenue CAGR: 8.99% | SUE: -1.43 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.28 | Chg7d=+0.000 | Chg30d=-0.011 | Revisions Net=-1 | Analysts=6
EPS current Year (2026-09-30): EPS=1.13 | Chg7d=+0.000 | Chg30d=-0.060 | Revisions Net=-6 | Growth EPS=-2.8% | Growth Revenue=+6.1%
EPS next Year (2027-09-30): EPS=1.17 | Chg7d=-0.003 | Chg30d=-0.008 | Revisions Net=-4 | Growth EPS=+3.9% | Growth Revenue=+0.1%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.1% (Discount Rate 8.1% - Earnings Yield 4.1%)
[Growth] Growth Spread = +4.9% (Analyst 9.0% - Implied 4.1%)